Tag: InMed Pharmaceuticals

January 20, 2020

InMed First to Advance Cannabinol into Therapeutic Clinical Trials

InMed Pharmaceuticals confirmed that CBN is the active pharmaceutical ingredient in its two product candidates under development.
August 5, 2019

Cannabis Investment: Canadian Cannabis Stocks

Are you interested in cannabis investment? Here's a list of Canadian marijuana stocks for investors to reference.
July 25, 2019

Invest in Cannabis: TSX Cannabis Stocks

Want to invest in cannabis? INN offers investors a growing list of cannabis companies listed on the TSX. See what...
April 9, 2019

5 Top Biotech Stocks on the TSX Q1 2019

Which biotech stocks on the TSX have performed the best in Q1 2019? Here's a look at those five top...
March 6, 2018

InMed Shares Research in Peer-Reviewed Publication

InMed Pharmaceuticals shared the publication of a peer-reviewed article Drug Delivery and Translational Research showing pre-clinical study results from research...
March 2, 2018

InMed Gets Conditional Approval for TSX Listing

InMed Pharmaceuticals announced it received conditional approval from the TSX to list its common shares in the exchange.
October 24, 2017

InMed Shares Pre-Clinical Data from Co-Sponsored Study

InMed Pharmaceuticals announced the results from a co-sponsored study with the University of British Columbia.